News
ARWR ▲ +3.0% - Arrowhead Pharmaceuticals, Inc.
ARWR ▲ +3.0% - Arrowhead Pharmaceuticals, Inc.
$ARWR - Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
14-OCT-2026 07:34 AM ET
Share this post
More filings for $ARWR
ARWR ▲ +0.4% - Arrowhead Pharmaceuticals, Inc.Nov 2, 2026ARWR ▲ +2.0% - Arrowhead Pharmaceuticals, Inc.Oct 27, 2026ARWR ▲ +0.7% - Arrowhead Pharmaceuticals, Inc.Oct 15, 2026ARWR ▲ +1.8% - Arrowhead Pharmaceuticals, Inc.Oct 7, 2026ARWR ▲ +1.8% - Arrowhead Pharmaceuticals, Inc.Oct 7, 2026ARWR ▼ -0.8% - Arrowhead Pharmaceuticals, Inc.Sep 3, 2026
View full $ARWR filing history →💬 Comments
Loading comments…
Leave a comment